title: Letter to the Editor.
authors.forename: Guenter
authors.initials: G
authors.lastname: Scheuerbrandt
mesh_terms: D002648:Child; D016189:Dystrophin / Q000235:genetics*; D005091:Exons; D006801:Humans; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy* / Q000235:genetics*; D009841:Oligonucleotides / Q000627:therapeutic use; D010069:Oxadiazoles / Q000627:therapeutic use; D012326:RNA Splicing; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: C484258:DMD protein, human; D016189:Dystrophin; D009841:Oligonucleotides; D010069:Oxadiazoles; C525434:PRO051; D014451:Ubiquinone; C036619:idebenone; C515878:ataluren